EMEA-001154-PIP01-11

Key facts

Invented name
ATryn
Active substance
Antithrombin alfa
Therapeutic area
Haematology-Hemostaseology
Decision number
P/226/2011
PIP number
EMEA-001154-PIP01-11
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
Treatment of antithrombin deficiency
Route(s) of administration
Intravenous use
Contact for public enquiries
Applicant: GTC Biotherapeutics UK Limited
Country: United States
E-mail: Dick.Scotland@gtc-bio.com
Phone: +1 5083705164
Fax: +1 5083705268
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating